Lockheed Martin Corp (LMT) 243.32 $LMT Lockheed Martin

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Lockheed Martin Corp (LMT) 243.32 $LMT

Lockheed Martin Delivers 2,000th JASSM® to the U.S. Air Force
PR Newswire - 13 mins ago
Lockheed Martin (NYSE: LMT) recently delivered the 2,000th Joint Air-to-Surface Standoff Missile (JASSM®) to the U.S. Air Force.
LMT: 243.32 (-0.29)

Lockheed's (LMT) Sikorsky Wins $135M Deal for 24 Black Hawks
Zacks Equity Research - Zacks Investment Research - Mon Sep 05, 7:33AM CDT
Among other models of the Black Hawk, Lockheed's (LMT) UH-60M is the most efficient, thanks to its integrated digital cockpit, moving map display, enhanced GPS/INS system and superior vertical lift.
GD: 153.81 (+0.97), EGL: 30.61 (+0.43), LMT: 243.32 (-0.29), DCO: 24.41 (+1.08), UTX: 106.93 (+0.21)

Ownership change voids Lockheed unit contract at Nevada site
By KEN RITTER - AP - Fri Sep 02, 2:04PM CDT
LAS VEGAS (AP) — Federal officials have rescinded a $5 billion contract awarded to a firm that had been a subsidiary of defense contractor Lockheed Martin Corp., just days after announcing the company would manage a vast former nuclear proving ground north of Las Vegas.
LMT: 243.32 (-0.29), NOC: 213.24 (+1.41), FLR: 52.14 (+0.61)

Lockheed Martin (LMT) Wins $204M Deal for Aegis BMD 5.1
Zacks Equity Research - Zacks Investment Research - Fri Sep 02, 8:32AM CDT
Lockheed Martin's (LMT) ABMD 5.1 will incorporate the SM-3 Block IIA, a new high-speed missile co-developed by the U.S. and Japan, into its combat system.
GD: 153.81 (+0.97), EGL: 30.61 (+0.43), LMT: 243.32 (-0.29), DCO: 24.41 (+1.08)

Warsaw University Of Technology Reaches "New Heights" In Unmanned Aerial Systems Optimization Research Partnership With Lockheed Martin
PR Newswire - Fri Sep 02, 8:15AM CDT
The Warsaw University of Technology (WUT) and Lockheed Martin (NYSE: LMT) successfully demonstrated their UAV optimization technologies using aerial command and control (C2) of multiple unmanned aerial vehicles (UAVs).
LMT: 243.32 (-0.29)

Bay Area Students: Take a Virtual Field Trip to Mars this September
PR Newswire - Thu Sep 01, 11:47AM CDT
NASA has a goal of sending humans to Mars in the 2030s, but to get there--and beyond--we must have the skilled workforce to get the job done.
LMT: 243.32 (-0.29)

InvestorsObserver releases covered-call reports for Starbucks, Intersil Corporation, Mercadolibre Incorporated, Lockheed Martin Corporation and Consolidated Edison
PR Newswire - Thu Sep 01, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for ED, ISIL, LMT, MELI, and SBUX.
SBUX: 56.18 (-0.13), LMT: 243.32 (-0.29), ED: 75.55 (+0.67), MELI: 186.16 (+12.48), ISIL: 20.20 (-0.05)

The Zacks Analyst Blog Highlights: Lockheed Martin, Harris, General Dynamics, Honeywell International and United Technologies
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 8:30AM CDT
The Zacks Analyst Blog Highlights: Lockheed Martin, Harris, General Dynamics, Honeywell International and United Technologies
HRS: 93.69 (+0.84), GD: 153.81 (+0.97), LMT: 243.32 (-0.29), HON: 116.39 (+0.26), UTX: 106.93 (+0.21)

Lockheed's (LMT) Sikorsky Wins Black Hawk Defense Deal
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 7:54AM CDT
Lockheed Martin Corp.'s (LMT) business unit, Sikorsky Aircraft Corp., has won a modification contract from the U.S. Army for exercising an option for 14 UH-60M helicopters.
EGL: 30.61 (+0.43), LMT: 243.32 (-0.29), DCO: 24.41 (+1.08), UTX: 106.93 (+0.21)

Javelin Joint Venture signs Letter of Intent with India's Tata Power
PR Newswire - Wed Aug 31, 7:00AM CDT
The Javelin(TM) Joint Venture team, a partnership between Raytheon Company (NYSE: RTN) and Lockheed Martin (NYSE: LMT), signed a letter of intent (LOI) with Tata Power Company Limited operating through its Strategic Engineering Division (SED), to explore co-development and production of the Javelin anti-armor missile system.
LMT: 243.32 (-0.29), RTN: 140.13 (+0.17)

Look for Shares of Lockheed Martin to Potentially Rebound after Yesterday's 1.94% Sell Off
Comtex SmarTrend(R) - Tue Aug 30, 12:18PM CDT
Lockheed Martin (NYSE:LMT) traded in a range yesterday that spanned from a low of $239.50 to a high of $243.31. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $243.65 on volume of 829,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
LMT: 243.32 (-0.29)

Watch for Lockheed Martin to Potentially Rebound After Falling 1.94% Yesterday
Comtex SmarTrend(R) - Tue Aug 30, 12:17PM CDT
Lockheed Martin (NYSE:LMT) traded in a range yesterday that spanned from a low of $239.50 to a high of $243.31. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $243.65 on volume of 829,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
LMT: 243.32 (-0.29)

Hybrid Airships Are Coming To Alaska
PR Newswire Europe - Tue Aug 30, 11:00AM CDT
PRL Logistics Teams with Straightline Aviation
LMT: 243.32 (-0.29)

Defense Stock Roundup: Lockheed Martin Secures Big Wins; HRS Boosts Dividend by 6%
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 10:41AM CDT
Mixed performance on the bourses on the one hand and a generous flow of funds from the Pentagon on the other formed the picture of the defense sector last week.
HRS: 93.69 (+0.84), GD: 153.81 (+0.97), LMT: 243.32 (-0.29), HON: 116.39 (+0.26), UTX: 106.93 (+0.21), TXT: 41.12 (+0.31), COL: 85.07 (+0.94), LLL: 149.89 (+0.55)

Lockheed Martin (LMT) Wins $287M Deal for C-130J Aircraft
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 7:51AM CDT
Lockheed Martin Corp. (LMT) has won a modification contract from the U.S. Air Force for the C-130J type aircraft.
GD: 153.81 (+0.97), EGL: 30.61 (+0.43), LMT: 243.32 (-0.29), DCO: 24.41 (+1.08)

Lockheed Martin unit to manage former Nevada nuke test site
AP - Fri Aug 26, 6:17PM CDT
LAS VEGAS (AP) — A subsidiary of defense giant Lockheed Martin has been awarded a $5 billion contract to manage a vast federal Department of Energy reservation where the nation used to conduct nuclear testing north of Las Vegas.
LMT: 243.32 (-0.29), NOC: 213.24 (+1.41), FLR: 52.14 (+0.61)

Lockheed Martin (LMT) Clinches $126M U.S. Navy Contract
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 9:21AM CDT
Lockheed Martin Corp.???s (LMT) Mission Systems and Training division recently won a contract from the U.S. Navy for engineering services and support of the Integrated Submarine Imaging Systems program.
GD: 153.81 (+0.97), EGL: 30.61 (+0.43), LMT: 243.32 (-0.29), DCO: 24.41 (+1.08)

Lockheed Martin, University of Colorado Boulder Create Multi-Million-Dollar Partnership
PR Newswire - Thu Aug 25, 1:00PM CDT
Lockheed Martin (NYSE: LMT) and the University of Colorado Boulder (CU) are establishing new academic programs through a multi-million-dollar agreement that will develop the next generation of space engineers. The Lockheed Martin Radio Frequency (RF) Space Systems Research Center will boost engineering expertise at the school and create new curriculum to fill in-demand skills in the space sector.
LMT: 243.32 (-0.29)

Aerospace Industry Brings Economic and Educational Opportunity to Colorado
PR Newswire - Wed Aug 24, 10:38AM CDT
The Colorado Space Business Roundtable (CSBR) is conducting an Aerospace Business Development Road Trip throughout western Colorado. CSBR is traveling to four communities to share how the aerospace industry benefits every community in Colorado.
LMT: 243.32 (-0.29)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 135

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 220

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 210

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 318

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 269

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 406

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 180

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 103

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 235

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading

Top 5 Most Recently Viewed Articles

Kulicke & Soffa Announces Conference Call for Fiscal Results

Updated Category News Views 122

Kulicke & Soffa Schedules Conference Call Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC), a leading name in semiconductor assembly technology, has announced a conference call to discuss its third fiscal quarter financial results and business outlook. The call is set for a future date, highlighting the company's commitment to transparency and communication with its...

Continue Reading
ARMOUR Residential REIT Launches Major Stock Offering for Growth

Updated Category News Views 162

ARMOUR Residential REIT Enters Public Stock Offering ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) has officially announced an underwritten public offering of 18,500,000 shares of common stock. The company is poised to grant underwriters an additional option to purchase up to 2,775,000 shares, making this a significant move for ARMOUR as it aims to enhance its...

Continue Reading
Celebrate Mother's Day with a Unique Brunch at Cannon + Belle

Updated Category News Views 195

Cannon + Belle Offers a Memorable Mother's Day Brunch Cannon + Belle at Hilton Austin is excited to announce an elevated Mother's Day brunch that promises to create unforgettable memories. This year, the restaurant will be hosting a special brunch event aimed at honoring mothers and all they do. With an impressive menu curated by the talented Chef Gereamy Cater, guests...

Continue Reading
Figma's Shares Surge in IPO But Valuation Remains a Concern

Updated Category News Views 244

Figma's Impressive IPO Performance Figma Inc. (NYSE: FIG) has captured significant investor attention following its explosive debut in the stock market. After launching its initial public offering, the company's shares skyrocketed by over 250%, marking a remarkable milestone for the firm. The stock began trading at a price of $33 per share, leading to approximately $1.2...

Continue Reading
Journey Medical Corporation's Emrosi Launch for Rosacea Relief

Updated Category News Views 215

Journey Medical Corporation Introduces Emrosi for Rosacea Treatment Journey Medical Corporation, a key player in the dermatological pharmaceutical industry, has recently launched Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules), designed for the effective treatment of rosacea. The product, featuring a unique formulation of 10 mg immediate release and...

Continue Reading